Premedication with pioglitazone prevents doxorubicin-induced left ventricular dysfunction in mice
Abstract Background Doxorubicin (DOX) is widely used as an effective chemotherapeutic agent for cancers; however, DOX induces cardiac toxicity, called DOX-induced cardiomyopathy. Although DOX-induced cardiomyopathy is known to be associated with a high cumulative dose of DOX, the mechanisms of its l...
Gespeichert in:
| Hauptverfasser: | , , , , , , , |
|---|---|
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
BMC
2021-05-01
|
| Schriftenreihe: | BMC Pharmacology and Toxicology |
| Schlagworte: | |
| Online-Zugang: | https://doi.org/10.1186/s40360-021-00495-w |
| Tags: |
Keine Tags, Fügen Sie das erste Tag hinzu!
|
